Clinical Trial Update: TP53 R248Q TCR-T Cell Therapy for Advanced Solid Tumor [EARLY_Phase 1]

View source ↗

Summary

Early-phase trial of TP53 R248Q-targeted TCR-T cell therapy for advanced solid tumors is not yet recruiting. The trial lists lung adenocarcinoma, pancreatic can…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Lung Adenocarcinoma
• Pancreatic Cancer

Drugs mentioned

• TP53 R248Q TCR-T Cell Therapy

Snippet

Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | Conditions: Solid Tumor, Adult, Lung Adenocarcinoma | EARLY_Phase 1 | Status: NOT_YET_RECRUITING